Impact of our model
Our not-for-profit model multiplies the impact of philanthropic investments and pharmaceutical know-how to alleviate the suffering of millions of children with rare diseases and their families
We are committed to use funding resources in a socially responsible manner. We reinvest all our profits to further achieve our mission, which is to develop treatments for underserved patients, improve their quality of life and drive affordable access to medicine.
Investments and financial returns enable EspeRare to establish itself as a major drug development player within the paediatric rare disease space and confirm its ability to accelerate accessible treatments for these underserved patients.